BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14751403)

  • 1. Differential involvement of mu 1-opioid receptors in dermorphin tetrapeptide analogues-induced antinociception.
    Mizoguchi H; Yuhki M; Watanabe H; Hayashi T; Sakurada C; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2004 Feb; 486(1):19-24. PubMed ID: 14751403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
    Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Yonezawa A; Sato T; Komatsu T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2011 Jan; 651(1-3):66-72. PubMed ID: 21047509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Sato T; Zadina JE; Kastin AJ; Sakurada T
    Peptides; 2002 May; 23(5):895-901. PubMed ID: 12084520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
    Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
    Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
    Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
    Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
    Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine.
    Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct physiological role of amidino-TAPA-sensitive and DAMGO-insensitive μ-opioid receptor splice variants in the mouse spinal cord.
    Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Aoki Y; Kon-no T; Takagi H; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2013 Jul; 711(1-3):80-6. PubMed ID: 23623932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors.
    Ukai M; Kobayashi T; Mori K; Shinkai N; Sasaki Y; Kameyama T
    Eur J Pharmacol; 1995 Dec; 287(3):245-9. PubMed ID: 8991797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit.
    Niijima F; Tan-No K; Esashi A; Nakagawasai O; Tadano T; Takahashi N; Yonezawa A; Sakurada S; Kisara K
    Peptides; 2000 Feb; 21(2):295-9. PubMed ID: 10764959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.